• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Hypertrophic cardiomyopathy (HCM) is a relatively common inherited myocardial disorder,
once regarded as largely untreatable with ominous prognosis and most visibly as a common …

Aims We investigated the prognostic role of left ventricular global longitudinal strain (LV-
GLS) and its incremental value to established risk models for predicting sudden cardiac …

The progress in the management of hypertrophic cardiomyopathy (HCM) over the last
several decades has resulted in great improvements in quality of life and overall survival for …

Hypertrophic cardiomyopathy (HCM) is one of the most common inheritable
cardiomyopathies. Contemporary management strategies, including the advent of …

We investigated sex-related differences in the prognosis of patients with hypertrophic
cardiomyopathy (HCM) using the Korea National Health Insurance Service database. From …

Objective: Given the psychosocial and ethical burden, patients with hypertrophic
cardiomyopathy (HCMs) could benefit from the establishment of genetic probability prior to …

Background and aims The cardiac societies of Europe and the United States have
established different risk models for preventing sudden cardiac death (SCD) in hypertrophic …

Background Hypertrophic cardiomyopathy (HCM) is the commonest genetic cardiomyopathy
and may result in sudden cardiac death (SCD). Clinical risk stratification scores are utilised …

Background: MRI native T1 mapping and extracellular volume fraction (ECV) are
quantitative values that could reflect various myocardial tissue characterization. The role of …